ATP5J expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.32200036975883E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.22350000131277E-08 |
Normal-vs-Stage2 |
1.85070000002785E-06 |
Normal-vs-Stage3 |
5.87340000000047E-05 |
Normal-vs-Stage4 |
1.743750E-03 |
Stage1-vs-Stage2 |
5.657600E-01 |
Stage1-vs-Stage3 |
7.777200E-01 |
Stage1-vs-Stage4 |
7.925600E-01 |
Stage2-vs-Stage3 |
7.562800E-01 |
Stage2-vs-Stage4 |
4.529000E-01 |
Stage3-vs-Stage4 |
6.516800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.41490210845564E-11 |
Normal-vs-AfricanAmerican |
2.582100E-04 |
Normal-vs-Asian |
2.059200E-01 |
Caucasian-vs-AfricanAmerican |
2.905500E-02 |
Caucasian-vs-Asian |
7.216600E-01 |
AfricanAmerican-vs-Asian |
6.754800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.29079968935741E-10 |
Normal-vs-Female |
1.95047000000059E-05 |
Male-vs-Female |
5.758400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.42979999956583E-07 |
Normal-vs-Extreme_Weight |
4.87410001248634E-09 |
Normal-vs-Obese |
4.760600E-04 |
Normal-vs-Extreme_Obese |
1.845150E-01 |
Normal_Weight-vs-Extreme_Weight |
8.765400E-01 |
Normal_Weight-vs-Obese |
5.471200E-01 |
Normal_Weight-vs-Extreme_Obese |
7.429200E-01 |
Extreme_Weight-vs-Obese |
4.428000E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.040600E-01 |
Obese-vs-Extreme_Obese |
9.371000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.681320E-03 |
Normal-vs-Age(41-60Yrs) |
5.44040001937418E-09 |
Normal-vs-Age(61-80Yrs) |
8.79920003526991E-09 |
Normal-vs-Age(81-100Yrs) |
1.94538999999105E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.336400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.224800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.963200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.236400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.739200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.435600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.39389952305658E-10 |
Normal-VS-Type2 PRCC |
1.75821999999215E-05 |
Normal-VS-KIRP CIMP |
5.14110000127133E-08 |
Normal-VS-Unclassified PRCC |
8.85549999996016E-08 |
Type1 PRCC-VS-Type2 PRCC |
1.455170E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.072600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
3.218400E-01 |
Type2 PRCC-VS-KIRP CIMP |
5.188000E-02 |
Type2 PRCC-VS-Unclassified PRCC |
4.762400E-02 |
KIRP CIMP-VS-Unclassified PRCC |
4.632800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.57850000001869E-06 |
Normal-vs-N1 |
1.403680E-04 |
Normal-vs-N2 |
1.89461999999807E-05 |
N0-vs-N1 |
6.124800E-01 |
N0-vs-N2 |
1.692170E-01 |
N1-vs-N2 |
2.557600E-01 |
|
|